Therapeutic potential of neutralizing antibodies in the treatment of HIV-1 infection.
Stiegler
Gabriela
G
Institute of Applied Microbiology, Vienna, Austria. G.Stiegler@iam.boku.ac.at
Katinger
Hermann
H
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000914:Antibodies, Viral / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000628:therapy*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007116:Immunization, Passive / Q000379:methods*
D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral